LED Medical Diagnostics' VELscope Vx® Wins Pride Institute's "Best of Class" Award

Maker of world’s leading adjunctive oral health screening device one of few companies to receive award for three consecutive years.
BURNABY, British Columbia – August 28, 2013 - LED Medical Diagnostics Inc. ("LED Medical", "the Company"), announced that its VELscope® Vx Enhanced Oral Assessment System has received the Pride Institute’s “Best of Class” Technology Award for 2013. This is the third consecutive year the company has received this prestigious award, which is designed to recognize dental industry products that demonstrate excellence in their respective categories. "We are truly honoured to be one of the very few to receive such an important award for the third consecutive year," said Peter Whitehead, Chief Executive Officer of LED Medical Diagnostics. "I am thrilled to see yet again that the technology leaders within the dental community believe in our technology as much as we and our customers do." The VELscope® Vx system is the world's leading adjunctive technology for the detection of cancer, pre-cancer and other oral disease that might not be apparent to the naked eye. Its popularity stems from the fact that its exams are completely non-invasive and affordable, take only two minutes, and have been shown by numerous clinical studies and extensive in-practice use to be highly effective. The VELscope® Vx is distributed exclusively by Den-Mat Holdings, LLC. The Pride Institute's panel, composed of leading voices in dental technology, comes together each year to discuss, debate and decide which products merit truly special recognition. All technology categories are considered, but if there is no clear differentiator that sets a product apart in its category, then no winner is selected. Each product honoured as "Best of Class" features unique characteristics that differentiate it from the competition in a compelling way and, more importantly, creates value for the general dentist. Organized by Dr. Lou Shuman, President of Pride Institute, the panel is committed to a selection method that is unbiased and rigorous. Throughout the course of the year, members of the panel review new and existing technologies in preparation for the vote. Panellists who receive compensation from a dental company are prevented from voting in that company's category. This facilitates a spirited debate and selection process that allows a variety of products — obscure and well-known, basic and aspirational — the chance to be honoured. More importantly, it provides the dental professional with a product perspective untainted by manufacturer intervention. "I am honored by the impact the award is having on purchasing decisions and its value to the manufacturing community," Dr. Lou Shuman, DMD, CAGS, Best of Class founder and President of Pride Institute shared, "but I am most proud of the integrity of our process and how it differentiates this award from any other provided today. The formula — technology leadership in dentistry, unbiased and not for profit — works. Even now, five years in, it is incredible to see this vision come to fruition thanks to the support of the panel, ADA, Dental Products Report, and Dental Economics." The panel consists of seven dentists with significant knowledge of and experience in dental technology, including Dr. Shuman; John Flucke, DDS, writer, speaker and Technology Editor for Dental Products Report; Paul Feuerstein, DMD, writer, speaker and Technology Editor for Dental Economics; Titus Schleyer, DMD, PhD, Associate Professor and Director, Center for Dental Informatics at the University of Pittsburg, School of Dental Medicine; Marty Jablow, DMD, technology writer and consultant for Dr. BiCuspid; Parag Kachalia, DDS, Vice-Chair of Preclinical Education, Research and Technology, University of Pacific School of Dentistry; and Larry Emmott, DDS, technology writer, speaker and dental marketing consultant. "The energy and true expertise that the panel brings to the table are true gifts to the profession," said Dr. Shuman. "I feel very fortunate to have each member as part of this process." The Pride Institute Best of Class Technology awards were launched in 2009 as a new concept to provide an unbiased, non-profit assessment of available technologies in the dental space. Through print and digital media coverage, the "Best of Class" message reaches the community of 150,000 dentists through multiple touch points — in print and online — educating them about the products. Honouree participation in the "Tech Expo" at the American Dental Association's Annual Session offers face-to-face interaction with the companies as well as technology-centered education provided by members of the panel as well as the esteemed consultants of Pride Institute. Courses at last year's 2012 meeting sold out. This year's event will be held October 31 – November 3 in New Orleans.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit www.ledmd.com. Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope® Vx devices are now used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. To date, there have been more than 13,000 VELscope® Vx systems sold globally and they have been used to perform more than 25 million exams. For more information, visit www.leddental.com.

For media or investor relations inquiries, please contact:

Mark Komonoski
Investor Relations
LED Medical Diagnostics Inc.
TSX.V: LMD | OTCQX: LEDIF | FSE: LME

Toll-Free: 877.255.8483
Office: 403.255.8483
Mobile: 403.470.8384
E-Mail:
Skype: mkomonoski

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.